Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $30.98 Analyst target: $74.20 Upside: 139.51%
Vera Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immune diseases in the United States. The company is headquartered in South San Francisco, California.
See the full interactive analysis & chart →Informational only — not investment advice.